Issue Date | Title | Author(s) |
2023-01 | 49 Burden and challenges of malignant bowel obstruction: a qualitative study | Baddeley, E; Bravington, A; Nelson, A; Johnson, MJ; Murtagh, FE; Currow, DC; Obita, G; Boland, EG; Seddon, K; Oliver, A; Noble, SI; Boland, JW |
2023 | Development of a Core Outcome Set for the research and assessment of inoperable malignant bowel obstruction. | Bravington, A; Obita, G; Baddeley, E; Johnson, MJ; Murtagh, FEM; Currow, DC; Boland, EG; Nelson, A; Seddon, K; Oliver, A; Noble, SIR; Boland, JW; Gilchrist, FJ |
2017-11-01 | Effect of Opioids and Benzodiazepines on Clinical Outcomes in Patients Receiving Palliative Care: An Exploratory Analysis | Boland, JW; Allgar, V; Boland, EG; Oviasu, O; Agar, M; Currow, DC; Johnson, MJ |
2023-03-14 | High-quality phase 3 studies do not support the use of somatostatin analogues to reduce vomiting in malignant bowel obstruction. | Boland, JW; Boland, EG; Currow, DC |
2017-03-01 | O-3 Opioids, benzodiazepines, anti-cholinergic load and clinical outcomes in patients with advanced cancer | Boland, JW; Allgar, V; Boland, EG; Oviasu, O; Agar, M; Currow, DC; Johnson, MJ |
2016-12-01 | Somatostatin Analogues Compared With Placebo and Other Pharmacologic Agents in the Management of Symptoms of Inoperable Malignant Bowel Obstruction: A Systematic Review | Obita, GP; Boland, EG; Currow, DC; Johnson, MJ; Boland, JW |
2022-06 | Symptom burden and lived experiences of patients, caregivers and healthcare professionals on the management of malignant bowel obstruction: A qualitative systematic review. | Baddeley, E; Mann, M; Bravington, A; Johnson, MJ; Currow, D; Murtagh, FEM; Boland, EG; Obita, G; Oliver, A; Seddon, K; Nelson, A; Boland, JW; Noble, SIR |
2022-10 | The range and suitability of outcome measures used in the assessment of palliative treatment for inoperable malignant bowel obstruction: A systematic review. | Bravington, A; Obita, G; Baddeley, E; Johnson, MJ; Murtagh, FE; Currow, DC; Boland, EG; Nelson, A; Seddon, K; Oliver, A; Noble, SI; Boland, JW |